Total Funding
42
9
Total FundingPost-IPO Debt raised
Growth Score
-11 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
510778
IMRIS provides an image-guided therapy environment, facilitating timely information to clinicians to use during surgical procedures.
Acquired by 
Grovecourt Capital Partners
William Fraser: DirectorPast Role: Bell MTS, President and Chief Executive Officer, and a Director
Steve Armstrong: DirectorPast Role: Patterson Companies, Vice President and CFO
About the Company
IMRIS provides an optimized fully integrated image guided therapy environment that delivers timely information to clinicians for use during surgical or interventional procedures. The VISIUS Surgical Theatre incorporates magnetic resonance imaging, CT and fluoroscopy into multi-purpose surgical suites to provide truly intra-operative imaging for
specific medical applications. Our products are sold globally to hospitals that deliver clinical services to patients in the neurosurgical, interventional neurovascular and cardiovascular markets.
The VISIUS Surgical Theatre is designed to address important needs of patients, clinicians and hospitals.
